@waynesworld
"It could be with a pharma or biotech who either wants to move into DMD or orphan disease indications more generally speaking or sees the opportunity for ATL1102 as a novel anti-inflammatory drug in multiple disease indications including MS and long Covid."
Wayno,
If the area of interest for potential partner is both DMD and the broader anti-inflammatory market across multiple diseases...then it would be a pretty large Pharma who has the resources and $$$ to go broad and big.
In this case, the partnership deal becomes a little more expensive in my opinion, if PER give rights for the full potential to one player.
Interesting times...
PER is full of connections to CSL - there is Moses, Gittleson, McKenzie... not quite in their wheelhouse but never say never.
.
- Forums
- ASX - By Stock
- PER
- PER - Megathread
PER - Megathread, page-79
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.23M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 35004 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.090 |
1 | 14567 | 0.088 |
2 | 174000 | 0.087 |
3 | 46981 | 0.086 |
1 | 100000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 42004 | 2 |
0.091 | 82805 | 1 |
0.093 | 250000 | 3 |
0.095 | 300000 | 1 |
0.096 | 100000 | 1 |
Last trade - 09.27am 05/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online